Impact of interleukin-28B polymorphism on HCV-1 infected patients treated with response-guided therapy

Conclusion For HCV-1 infected patients who were treated with RGT, the IL28B unfavorable genotype predicted a higher relapse rate; RVR and IL28B favorable genotype were independent factors associated with SVR in patients treated with RGT.
Source: Advances in Digestive Medicine - Category: Gastroenterology Source Type: research